SUBSCRIPTION AGREEMENT, dated as of February 28, 2002, between
MERRIMAC INDUSTRIES INC., a Delaware corporation ("Merrimac"), and DUPONT
CHEMICAL AND ENERGY OPERATIONS, INC. ("DCEO"), a Delaware corporation and
wholly-owned subsidiary of E.I. DU PONT DE NEMOURS AND COMPANY, a Delaware
corporation ("DuPont"), and (solely with respect to Section 3.1(b) hereof)
DUPONT.
WHEREAS, Merrimac desires to sell to DCEO, and DCEO desires to
purchase from Merrimac, shares of Merrimac's Common Stock, $0.01 par value per
share (the "Common Stock"), in accordance with the terms herein set forth.
NOW, THEREFORE, the parties agree as follows:
1. Purchase and Sale of Securities.
1.1 Sale and Issuance of Purchased Shares. Merrimac shall issue and
sell to DCEO, and DCEO shall purchase from Merrimac, 528,413 shares of Common
Stock, which is the number of whole shares of Common Stock (the "Purchased
Shares") that equals 19.9% of the number of outstanding shares of Common Stock
on the Closing Date (as defined in Section 1.2 hereof), prior to giving effect
to this transaction, at a price of $10.00 per share (the "Purchase Price").
1.2 Closing. The purchase and sale of the Purchased Shares shall take
place at the offices of Rosenman & Colin LLP, 575 Madison Avenue, New York,
New York, on February 28, 2002, or at such other time and place as the parties
shall agree (the "Closing"; the date on which the Closing occurs is
hereinafter referred to as the "Closing Date").
1.3 Delivery. At the Closing, Merrimac shall deliver to DCEO a
certificate representing the Purchased Shares, against payment by DCEO of the
Purchase Price. The Purchase Price shall be paid by wire transfer of
immediately available funds to Merrimac's account.
2. Representations and Warranties of Merrimac. Merrimac hereby represents
and warrants to DCEO that:
2.1 Corporate Organization and Authority. Merrimac (i) is a
corporation duly organized, validly existing and in good standing under the
laws of the State of Delaware, (ii) has the corporate power to own or lease
its properties and to carry on its business and (iii) is duly qualified and in
good standing as a foreign corporation authorized to do business in every
jurisdiction, except where the failure to so qualify would have a material
adverse effect on the business, results of operations or financial condition
(including accruals for environmental liabilities) of Merrimac and its
subsidiaries (a "Material Adverse Effect").
2.2 Due Authorization. Merrimac (i) has the requisite corporate power
and authority to execute and deliver this Agreement and the Registration
Rights Agreement, Employee Loan Agreement and MOU (each as hereinafter
defined, and collectively with this
Agreement, the "Transaction Agreements") and to perform its obligations
thereunder and (ii) has been authorized by all necessary corporate action to
execute and deliver the Transaction Agreements and to perform its obligations
thereunder. Each of the Transaction Agreements is a valid and binding
obligation of Merrimac enforceable in accordance with its terms.
2.3 Capitalization. The authorized capital stock of Merrimac consists
of (i) 20,000,000 shares of Common Stock, of which 2,655,345 shares are
outstanding, and (ii) 1,000,000 shares of preferred stock, $0.01 par value per
share, none of which is outstanding. All outstanding shares of Common Stock
were duly authorized and validly issued and are fully paid and non-assessable.
Except as set forth on Schedule 2.3 hereto, there are (i) no outstanding
subscriptions, warrants, options, conversion privileges or other rights or
agreements to purchase or otherwise acquire or issue any shares of capital
stock of Merrimac, (ii) no preemptive rights or rights of first refusal with
respect to the issuance of any shares of capital stock of Merrimac, and
(iii) no commitments or understandings (oral or written) of Merrimac to issue
any shares of capital stock of the Company. Except as set forth in the Merrimac
Reports (as hereinafter defined), none of the outstanding shares of Common Stock
are subject to any shareholders' agreement, voting trust agreement or similar
arrangement or understanding. Merrimac has no outstanding bonds, debentures,
notes or other obligations the holders of which have the right to vote (or which
are convertible into or exercisable for securities having the right to vote)
with the stockholders of Merrimac on any matter.
2.4 Validity of Purchased Shares. The issuance of the Purchased
Shares has been duly authorized, and when issued, sold and delivered in
accordance with the terms hereof and for the consideration set forth herein,
shall be validly issued, fully paid and non-assessable and free and clear of
all encumbrances and restrictions, except for restrictions on transfers
imposed by applicable securities laws and this Agreement.
2.5 Private Offering. Neither Merrimac nor anyone acting on its
behalf has, within the last 12 months, issued, sold or offered any security of
Merrimac to any Person under circumstances that would cause the issuance and
sale of the Purchased Shares pursuant to this Agreement to be subject to the
registration requirements of the Securities Act of 1933 (the "Securities
Act"). Merrimac agrees that neither Merrimac nor anyone acting on its behalf
will offer any securities similar to the Purchased Shares for issuance or sale
to, or solicit any offer to acquire any of the same from, any Person so as to
make the issuance and sale of the Purchased Shares subject to the registration
requirements of the Securities Act. As used herein, "Person" shall mean any
individual, sole proprietorship, partnership, corporation, limited liability
company, business trust, unincorporated association, joint stock corporation,
trust, joint venture or other entity.
2.6 Brokers and Finders. Merrimac has not retained any investment
banker, broker or finder in connection with the transactions contemplated by
this Agreement.
2.7 No Conflict. The execution and delivery of the Transaction
Agreements by Merrimac does not, and the performance by Merrimac of its
obligations thereunder will not,
2
(i) violate the Certificate of Incorporation or By-Laws of Merrimac, (ii)
violate any law, rule, regulation, order, judgment or decree applicable to
Merrimac or by which any property or asset of Merrimac is bound or affected,
or (iii) result in any breach of or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or result
in the creation of a lien or other encumbrance on any property or asset of
Merrimac pursuant to, any note, bond, mortgage, indenture, contract,
agreement, lease, license, permit, franchise or other instrument or obligation
to which Merrimac is a party or by which Merrimac or any property or asset of
Merrimac is bound or affected, except, in the case of clauses (ii) and (iii)
above, for any such violations, breaches, defaults or other occurrences which
would not prevent or delay consummation of any of the transactions
contemplated by the Transaction Agreements in any material respect, or
otherwise prevent Merrimac from performing its obligations under the
Transaction Agreements in any material respect, and would not, individually or
in the aggregate, have a Material Adverse Effect.
2.8 Required Filings and Consents. The execution and delivery of the
Transaction Agreements by Merrimac does not, and the performance by Merrimac
of its obligations thereunder will not, require any consent, approval,
authorization or permit of, or filing with or notification to, any
governmental body except for applicable requirements, if any, of the
Securities Exchange Act of 1934 (the "Exchange Act").
2.9 Compliance. Except as set forth on Schedule 2.9 hereto, Merrimac
and its subsidiaries are in compliance in all material respects with all
requirements of law, and no claims or complaints from any governmental body
have been received by Merrimac or any of its subsidiaries and, to the
knowledge of Merrimac, no claims or complaints are threatened, alleging that
Merrimac or any of its subsidiaries is in violation of any such requirement of
law except for such claims or complaints which have not had, individually or
in the aggregate, a Material Adverse Effect.
2.10 SEC Documents. (a) Merrimac has filed all forms, reports and
documents required to be filed by it with the Securities and Exchange
Commission (the "SEC") since January 1, 2000 (collectively, the "Merrimac
Reports"). As of their respective dates, the Merrimac Reports (i) complied as
to form in all material respects with the applicable requirements of the
Securities Act, the Exchange Act, and the rules and regulations thereunder and
(ii) did not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the
statements made therein, in the light of the circumstances under which they
were made, not misleading. The representation in clause (ii) of the preceding
sentence shall not apply to any misstatement or omission in any Merrimac
Report which was specifically superseded by a subsequent disclosure in a
Merrimac Report.
(b) The financial statements of Merrimac included in the Merrimac
Reports (including the related notes and schedules) fairly present in all
material respects the consolidated financial position of Merrimac as of the
dates thereof and the consolidated results of operations, retained earnings
and cash flows of Merrimac for the periods set forth therein (subject, in the
3
case of unaudited statements, to normal year-end audit adjustments which would
not be material in amount or effect), in accordance with generally accepted
accounting principles.
2.11 Litigation. Except as set forth in the Merrimac Reports, there
are no claims, actions, suits, investigations, inquiries or proceedings
pending against Merrimac or any of its subsidiaries or, to the knowledge of
Merrimac, threatened against Merrimac or any of its subsidiaries, at law or in
equity, or before or by any court, tribunal, arbitrator, self-regulatory
organization including the American Stock Exchange ("SRO"), mediator or any
federal or state commission, board, bureau, agency or instrumentality, that,
individually or in the aggregate, would reasonably be expected to have a
Material Adverse Effect. Neither Merrimac nor any of its subsidiaries is a
party to or subject to the provisions of any order, writ, injunction, judgment
or decree of any court or government agency or instrumentality or SRO.
2.12 Absence of Certain Changes. Except as disclosed in the Merrimac
Reports, since September 30, 2001 (a) neither Merrimac nor any of its
subsidiaries has incurred any liabilities or obligations (whether absolute or
contingent) other than those arising from operations in the ordinary course of
business consistent with past practice and (b) there has not been (i) any
event, occurrence, development or circumstances with respect to the business,
results of operations or financial condition of Merrimac or any of its
subsidiaries, other than events, occurrences, developments or circumstances
which have not had, individually or in the aggregate, a Material Adverse
Effect, (ii) any return of any capital or other distribution of assets to
stockholders of Merrimac; (iii) any acquisition (by merger, consolidation,
acquisition of stock and/or assets or otherwise) of any Person; (iv) any
transactions, other than in the ordinary course of business, with any of its
officers, directors, principal stockholders or employees or any Person
affiliated with any of such persons; or (v) any existing, pending or, to the
knowledge of Merrimac, threatened termination, cancellation, limitation,
modification or change in the business relationship of Merrimac with any
supplier, customer or other Person that would reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect.
2.13 Intellectual Property. To Merrimac's knowledge, Merrimac and
each of its subsidiaries owns or possesses sufficient legal rights to the
patents, patent rights, licenses, inventions, copyrights, know-how (including
trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures) and other rights or interests
in items of intellectual property (collectively, the "Proprietary Rights") as
are necessary for the operation of the business conducted by Merrimac and its
subsidiaries. To Merrimac's knowledge, the business of Merrimac and its
subsidiaries does not infringe upon or violate any Proprietary Rights of
others except where such infringement or violation, individually or in the
aggregate, would not have a Material Adverse Effect.
2.14 Registration Rights. Except as set forth in Schedule 2.14
hereto, Merrimac is not under any obligation to register under the Securities
Act any of its currently outstanding securities or any securities issuable
upon exercise or conversion of its currently outstanding securities.
4
2.15 Disclosure. No representation or warranty of Merrimac herein
contains any untrue statement of a material fact or omits to state a material
fact necessary in order to make the statements contained herein or therein, in
light of the circumstances under which they were made, not misleading.
2.16 DGCL Section 203. The restrictions in Section 203(a) of the
Delaware General Corporation Law do not apply to Merrimac.
2.17 Anti-Dilution. Except as set forth on Schedule 2.17, Merrimac
has taken all necessary action to ensure that no provision in any of its
governing documents, any shareholder rights plan or any agreements to which it
is a party would, as a result of this Agreement or the transactions
contemplated thereby, have a dilutive effect on DCEO's equity interest in
Merrimac as contemplated by this Agreement.
2.18 Title to Properties. Merrimac has good and marketable title to
all of its owned properties and assets, free and clear of violation of any
material zoning, building or safety ordinance, regulation or requirement or
other law or regulation applicable to the operations of its owned or leased
properties, and has not received any notice of violation with which it has not
complied or cured, as applicable.
2.19 Tax Matters. All foreign, federal, state, county or local income
tax returns of Merrimac have been either been filed, or valid unexpired
extensions of the due dates have been obtained and except as set forth on
Schedule 2.19, all foreign, federal, state, county and local taxes reported
thereon have been paid. The information provided on such tax returns is
complete and accurate in all material respects. There are no taxes owed to
foreign jurisdictions. There exist no unpaid assessments nor to Merrimac's
knowledge any basis for assessment of additional foreign, federal, state,
local or county income taxes on Merrimac for any fiscal period. Merrimac has
not waived any statute of limitations with respect to taxes and has not agreed
to any extension of time with respect to any tax assessment or deficiency.
2.20 Environmental Matters. Except as set forth on Schedule 2.20,
there are no legal, administrative, arbitral or other proceedings, claims,
actions, causes of action, required environmental remediation activities or,
to the knowledge of Merrimac, governmental investigations of any nature
seeking to impose, or that reasonably could be expected to result in the
imposition, on Merrimac or any of its subsidiaries of any liability or
obligation arising under common law standards relating to environmental
protection, human health or safety, or under any local, state, federal,
national or supernational environmental statute, regulation or ordinance,
including the Comprehensive Environmental Response, Compensation and Liability
Act of 1980, as amended (collectively, "Environmental Laws"), pending or, to
the knowledge of Merrimac, threatened, against Merrimac or any of its
subsidiaries, which liability or obligation would reasonably be expected to
have a Material Adverse Effect. To the knowledge of Merrimac, during or prior
to the period of (i) its or any subsidiaries' ownership or operation of any of
their respective current properties, (ii) its or any of its subsidiaries'
participation in the management of any property or (iii) its or any of its
subsidiaries' holding of a security interest or other interest in
5
any property, there was no release or threatened release of materials defined
as hazardous, toxic, radioactive or dangerous materials or other materials
regulated under Environmental Laws in, on, under or affecting any such
property which would reasonably be expected to have a Material Adverse Effect.
Neither Merrimac nor any of its subsidiaries is subject to any agreement,
order, judgment, decree, letter or memorandum by which or with any court,
governmental authority, regulatory agency or third party imposing any material
liability or obligations pursuant to or under any Environmental Law that would
reasonably be expected to have a Material Adverse Effect.
2.21 No Change of Control. The consummation of the transactions
contemplated by this Agreement shall not, either alone or in combination with
another event, entitle any current or former employee or officer of Merrimac
to severance pay or any other payment or accelerate the time of payment or
vesting or increase the amount of compensation due any such employee or
officer.
3. Representations and Warranties of DCEO. DCEO represents and warrants to
Merrimac that:
3.1 Due Authorization. (a) DCEO (i) is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware
and is a wholly-owned subsidiary of DuPont, (ii) has the requisite corporate
power and authority to execute and deliver the Transaction Agreements to which
it is a party and to perform its obligations thereunder and (iii) has been
authorized by all necessary corporate action to execute and deliver the
Transaction Agreements to which it is a party and to perform its obligations
thereunder. Each of the Transaction Agreements to which it is a party is a
valid and binding obligation of DCEO enforceable in accordance with its terms.
(b) DuPont (i) is a corporation duly organized, validly
existing and in good standing under the laws of the State of Delaware, (ii)
has the requisite corporate power and authority to execute and deliver the
Transaction Agreements to which it is a party and to perform its obligations
thereunder and (iii) has been authorized by all necessary corporate action to
execute and deliver the Transaction Agreements to which it is a party and to
perform its obligations thereunder. Each of the Transaction Agreements to
which it is a party is a valid and binding obligation of DuPont enforceable in
accordance with its terms.
3.2 Brokers and Finders. DCEO has not retained any investment banker,
broker or finder in connection with the transactions contemplated by this
Agreement.
3.3 Securities Laws Representations and Covenants of DCEO. (a) The
Purchased Shares will be acquired by DCEO for investment purposes only and for
its own account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof such that DCEO would be considered an
"underwriter" under the Securities Act; DCEO has not granted any right to any
other Person to acquire any of the Purchased Shares and agrees that the
Purchased Shares may not be sold or transferred without registration under the
Securities
6
Act or an exemption therefrom, and acknowledges that other than as provided
herein, it is required to hold the Purchased Shares for at least two years from
the Closing Date.
(b) DCEO acknowledges that the offering of the Purchased
Shares pursuant to this Agreement will not be registered under the Securities
Act on the grounds that the offering and sale of the Purchased Shares are
exempt from registration under the Securities Act, and that Merrimac's
reliance upon such exemption is predicated upon DCEO's representations set
forth in this Agreement.
(c) DCEO agrees that, unless the disposition of the
Purchased Shares has been registered under the Securities Act, DCEO will not
dispose of any Purchased Shares unless and until DCEO shall have notified
Merrimac of the proposed disposition, which notification may be made
concurrently with the disposition, and, upon the request of Merrimac, shall
furnish Merrimac with information reasonably satisfactory in form and
substance to Merrimac to the effect that such disposition will not require
registration under the Securities Act.
(d) DCEO (i) is able to fend for itself in the
transactions contemplated by this Agreement; (ii) has such knowledge and
experience in financial and business matters as to be capable of evaluating
the merits and risks of its prospective investment in the Purchased Shares;
(iii) has the ability to bear the economic risks of its prospective investment
and can afford the complete loss of such investment; (iv) has received all the
information it considers necessary and appropriate for deciding whether to
purchase the Purchased Shares; (v) has been furnished with and has had access
to the Merrimac Reports together with the opportunity to obtain such
additional information as it requested to verify the accuracy of the
information supplied; (vi) has had access to officers of Merrimac and an
opportunity to ask questions of and receive answers; and (vii) qualifies as an
"accredited investor", as such term is defined under Rule 501 promulgated
under Regulation D of the Securities Act.
3.4 Transfer Restrictions. (a) DCEO agrees not to sell, assign or
otherwise transfer (a "Transfer") any Purchased Shares to any competitor of
Merrimac or Person (or group of Persons) who have filed and not withdrawn a
Schedule 13D indicating a plan to seek control of Merrimac (such competitor or
other Person or group of Persons being hereinafter referred to as a
"Non-Qualified Person"); provided that the foregoing shall not apply to
Transfers (i) to the public pursuant to a registration statement for an
underwritten offering, provided that DCEO shall not make such a Transfer
knowingly to a Non-Qualified Person; (ii) pursuant to Rule 144 under the
Securities Act or (iii) in connection with a change of control of Merrimac,
including a sale of more than 50% of the outstanding shares of Common Stock.
Merrimac and DCEO have heretofore agreed on the Persons which shall be deemed
to be competitors of Merrimac. Merrimac shall have the right, with the consent
of DCEO, which consent shall not be unreasonably delayed or withheld, to add
Persons, at any time or from time to time, which shall be deemed to be
competitors of Merrimac.
(b) DCEO agrees not to Transfer any of the Purchased
Shares to any Person except as otherwise provided herein, during the period
from the Closing Date until the second
7
anniversary of the Closing Date. Notwithstanding anything contained herein,
however, DCEO may, at any time, transfer the Purchased Shares to any affiliate
of DCEO that is also a wholly-owned subsidiary, directly or indirectly, of
DuPont. The rights and obligations of DCEO pursuant to this Agreement and the
Registration Rights Agreement shall automatically apply to a permitted
transferee under this Section 3.4(b).
3.5 Legends. All certificates for the Purchased Shares and each
certificate representing any shares of capital stock of Merrimac received in
respect of the foregoing, whether by reason of a stock split or share
reclassification thereof, a stock dividend thereon or otherwise, shall bear
the following legend:
"THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A
SUBSCRIPTION AGREEMENT DATED AS OF FEBRUARY 28, 2002, AS THE
SAME MAY BE AMENDED FROM TIME TO TIME, PURSUANT TO THE TERMS
OF WHICH THE TRANSFER OF SUCH SHARES IS RESTRICTED. A COPY
OF SUCH AGREEMENT WILL BE FURNISHED WITHOUT CHARGE BY THE
ISSUER TO THE HOLDER HEREOF UPON REQUEST."
"THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN
ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933. SUCH SHARES MAY NOT BE SOLD OR
TRANSFERRED IN THE ABSENCE OF REGISTRATION OR AN EXEMPTION
THEREFROM UNDER SAID ACT."
4. Conditions to Closing.
4.1 Conditions to DCEO's Obligations at the Closing. DCEO's
obligation to purchase the Purchased Shares at the Closing is subject to the
satisfaction, at or prior to the Closing, of the following conditions:
(a) Representations and Warranties. The representations
and warranties made by Merrimac in Article 2 hereof which are subject to a
materiality standard shall be true and correct as of the Closing Date with the
same force and effect as if they had been made on and as of the Closing Date,
and the representations and warranties made by Merrimac in Article 2 hereof
which are not subject to a materiality standard shall be true and correct in
all material respects as of the Closing Date with the same force and effect as
if they had been made on and as of the Closing Date.
(b) Performance of Obligations. Merrimac shall have
performed all agreements herein required to be performed by it on or prior to
the Closing Date.
8
(c) Consents, Permits, and Waivers. Merrimac shall have
obtained any and all consents, permits and waivers necessary or appropriate
for consummation of the transactions contemplated by the Transaction
Agreements (except for such as the parties agree may be properly obtained
subsequent to the Closing).
(d) Due Diligence. DCEO shall have completed, to its
satisfaction, its due diligence review of Merrimac and its operations
including, without limitation, financial, technical, legal, corporate and
safety, health and environmental.
(e) Registration Rights' Agreement. The Registration
Rights' Agreement shall have been executed and delivered by the parties
thereto in the form attached hereto as Exhibit A (the "Registration Rights
Agreement").
(f) Employee Loan Agreement. The Employee Loan Agreement
shall have been executed and delivered by the parties thereto in the form
attached hereto as Exhibit B (the "Employee Loan Agreement").
(g) Memorandum of Understanding. The Memorandum of
Understanding between DuPont and Merrimac ("MOU") shall have been executed and
delivered by the parties thereto in the form attached hereto as Exhibit C.
(h) Legal Opinion. The delivery of a legal opinion from
Merrimac's counsel, in the form attached hereto as Exhibit D.
4.2 Conditions to Obligations of Merrimac at the Closing. Merrimac's
obligation to issue and sell the Purchased Shares at the Closing is subject to
the satisfaction, at or prior to the Closing, of the following conditions:
(a) Representations and Warranties. The representations
and warranties made by DCEO in Article 3 hereof which are subject to a
materiality standard shall be true and correct as of the Closing Date with the
same force and effect as if they had been made on and as of the Closing Date,
and the representations and warranties made by DCEO in Article 3 hereof which
are not subject to a materiality standard shall be true and correct in all
material respects as of the Closing Date with the same force and effect as if
they had been made on and as of the Closing Date.
(b) Performance of Obligations. DCEO shall have
performed all agreements herein required to be performed by it on or before
the Closing Date.
(c) American Stock Exchange Approval. Merrimac shall
have received approval from the American Stock Exchange that the execution and
delivery of the Transaction Agreements and consummation of the transactions
contemplated thereunder do not require approval of Merrimac's stockholders.
9
(d) Consents, Permits, and Waivers. Merrimac shall have
obtained any and all consents, permits and waivers necessary or appropriate
for consummation of the transactions contemplated by the Transaction
Agreements (except for such as the parties agree may be properly obtained
subsequent to the Closing).
(e) Employee Loan Agreement. The Employee Loan Agreement
shall have been executed and delivered by the parties thereto.
(f) Memorandum of Understanding. The MOU shall have been
executed and delivered by the parties thereto.
5. Affirmative Covenants of Merrimac.
Merrimac hereby covenants and agrees as follows:
5.1 No Solicitation. Between the date of this Agreement and the
Closing Date, Merrimac shall not, and shall not authorize or permit any of its
directors, officers, representatives, subsidiaries, affiliates or associates
to, (i) initiate contact with, solicit, encourage or disclose, directly or
indirectly, any information concerning Merrimac's business or properties to,
(ii) afford any access to Merrimac's personnel, offices, facilities,
properties, books and records to, or (iii) enter into any discussion,
negotiation or agreement with, any person or entity (other than DCEO or any of
its affiliates) in connection with the acquisition of, or any proposal for the
acquisition of, any Common Stock, or options, warrants or other securities to
purchase, convert or exchange such securities for Common Stock, or the assets
or business of Merrimac, except in the exercise by Merrimac's Board of
Directors of its fiduciary obligation to Merrimac's stockholders with respect
to unsolicited offers received by Merrimac, in which case Merrimac or its
Board shall have a legal opinion issued to DCEO confirming the requirement of
the exercise of such fiduciary duty. Merrimac shall immediately (i)
communicate to DCEO the terms of any proposal or other communication it may
receive or of which it may become aware and (ii) furnish DCEO with a true,
complete and correct copy of any such written proposal or communication and
any document relating thereto.
5.2 Conduct of Business. Between the date of this Agreement and the
Closing Date, Merrimac shall not take any material action that is outside the
ordinary course of business or inconsistent with past practices that would
cause a Material Adverse Effect.
5.3 Preemptive Right. At all times while DCEO is the record owner of
any of the Purchased Shares, DCEO shall have the right to purchase the number
of shares of Common Stock, or other securities convertible into or exercisable
for Common Stock (collectively, the "Securities"), that Merrimac may hereafter
issue equal to the product of (x) the number of shares of such Securities and
(y) a fraction, the numerator of which is the total number of Purchased Shares
owned by DCEO immediately prior to any such issuance and the denominator of
which is the total number of shares of Common Stock outstanding immediately
prior to such issuance (the "Preemptive Right"), strictly in accordance with
this Section 5.3. Such number of Securities that DCEO is entitled to purchase
are referred to as DCEO's "Pro Rata Share."
10
(a) Prior or immediately subsequent to the issuance of any
Securities, Merrimac shall give notice to DCEO stating (i) its bona fide
intention to issue or its issuance of Securities and a detailed description of
such Securities, (ii) the aggregate number of such Securities proposed to be
issued or issued, and (iii) the price and terms upon which it proposes to issue
or has issued such Securities.
(b) Within 15 calendar days after giving such notice to
DCEO, DCEO may elect, by giving notice to Merrimac, to purchase, at the same
price and on the same terms specified in such notice, all, but not less than
all, of the number of shares or other securities equal to DCEO's Pro Rata Share.
If DuPont either (i) fails to give notice to Merrimac of its intent to exercise
its Preemptive Right within such 15-day period or (ii) otherwise determines not
to exercise its Preemptive Right hereunder, DCEO's Preemptive Right shall expire
with respect to such issuance.
(c) DCEO's Preemptive Rights shall not be applicable to
(i) the issuance or sale of shares of Common Stock (or options therefor) to
Company employees, directors, officers or consultants pursuant to a stock
option, stock issuance or other incentive plan approved by Merrimac's Board of
Directors, (ii) the issuance of Common Stock pursuant to the conversion or
exercise of securities convertible into or exercisable for Common Stock with
respect to which DCEO has previously exercised, or was given the opportunity to
exercise and failed to exercise, its Preemptive Right and (iii) the issuance of
securities in connection with a bona fide business acquisition by Merrimac,
whether by merger, consolidation, purchase of assets, purchase or exchange of
stock, or otherwise.
(d) Notwithstanding anything to the contrary contained
herein, upon the issuance of Common Stock pursuant to the exercise of any
warrants outstanding on the Closing Date and listed in Schedule 5.3 hereto,
DCEO's Preemptive Right shall be to purchase DCEO's Pro Rata Share of such
Common Stock at a purchase price per share equal to the average closing price of
the Common Stock as reported on the American Stock Exchange on the 25 trading
days immediately preceding the date of the issuance of the Common Stock upon
such exercise.
(e) For the purposes of this Article 5, the term
"Purchased Shares" shall include all shares of Merrimac's capital stock issued
on or with respect to the Purchased Shares, whether by stock dividend, stock
split or recapitalization.
5.4 Board Representation. As long as DCEO continues to own at least
400,000 shares of the Purchased Shares acquired at the Closing, DCEO shall have
an option to designate one nominee (such individual is hereinafter referred to
as a "DuPont Designee(s)"), who must be a DCEO or DuPont employee, to the Board
of Directors. If Merrimac increases the number of directors to nine or more
members, exclusive of any directorships held by a DuPont Designee, then DCEO
shall have the option to designate, in its sole discretion, additional nominees,
who must be DCEO or DuPont employees, to the Board of Directors so that, at the
earliest possible time after such increase, the number of directorships held by
DCEO shall be the number determined in accordance with Schedule 5.4 hereto. If
DCEO exercises its option to
11
designate a nominee or nominees, as the case may be, to the Board of Directors,
then Merrimac shall use its best efforts, as promptly as possible, to have the
DCEO nominee(s) elected to the Board of Directors. At each annual meeting of the
stockholders of Merrimac and at each special meeting of the stockholders of
Merrimac involving the election of directors of Merrimac, and at any other time
at which stockholders of Merrimac will have the right to or will vote for or
consent in writing regarding the election of directors of Merrimac, Merrimac
agrees that, upon the request of DCEO, it will use its best efforts to cause and
maintain the election to the Board of Directors of the DuPont Designee(s). Upon
disposition in any manner by DCEO of an amount of the Purchased Shares that
results in it owning less than 400,000 shares of the Purchased Shares acquired
at the Closing, DCEO shall forfeit its right to designate a nominee(s) to the
Board of Directors of Merrimac and immediately upon such disposition, the DuPont
Designee(s), as the case may be, shall resign as a member(s) of the Board of
Directors of Merrimac. Until DCEO exercises its option to designate a nominee to
the Board of Directors and for as long as DCEO maintains an equity position of
250,000 shares of Common Stock, or if for any reason DCEO's designee has not
been elected to the Board of Directors, DCEO shall have the right to have an
observer present at all Board of Director meetings and any committee meetings of
the Board of Directors and to receive adequate notice of such meetings and a
copy of any materials distributed in connection therewith.
5.5 Further Assurances. For as long as DCEO owns any of the Purchased
Shares, Merrimac shall take all reasonable actions, including providing an
appropriate legal opinion, to preserve and maintain DCEO's right and ability to
sell the Purchased Shares under Rule 144 of the Securities Act and to maintain
DCEO's other rights under this Agreement.
6. Indemnification.
6.1 To the extent permitted by law, Merrimac will indemnify and hold
harmless DCEO against any losses, claims, damages, or liabilities (joint or
several) which DCEO may suffer, incur or pay by reason of (i) a breach by
Merrimac of any representation or warranty made by it in this Agreement or (ii)
a breach or failure of Merrimac to perform any agreement required by this
Agreement; provided, however, that the indemnity agreement contained in this
Section 6.1 shall not apply to amounts paid in settlement of any such loss,
claim, damage, liability or action if such settlement is effected without the
consent of Merrimac, which consent shall not be unreasonably withheld.
6.2 To the extent permitted by law, DCEO will indemnify and hold
harmless Merrimac against any losses, claims, damages, or liabilities (joint or
several) which Merrimac may suffer, incur or pay by reason of (i) a breach by
DCEO of any representation or warranty made by it in this Agreement or (ii) a
breach or failure of DCEO to perform any agreement required by this Agreement;
provided, however, that the indemnity agreement contained in this Section 6.2
shall not apply to amounts paid in settlement of any such loss, claim, damage,
liability or action if such settlement is effected without the consent of DCEO,
which consent shall not be unreasonably withheld.
12
6.3 Promptly after receipt by an indemnified party under this Section
6.3 of notice of the commencement of any action (including any governmental
action), such indemnified party will, if a claim in respect thereof is to be
made against any indemnifying party under this Section 6, deliver to the
indemnifying party a written notice of the commencement thereof and the
indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires (except as provided herein) to assume the
defense thereof with counsel mutually satisfactory to the parties; provided,
however, that an indemnified party shall have the right to retain one separate
counsel and to control its own defense, with the fees and expenses to be paid by
the indemnifying party, if representation of such indemnified party by the
counsel retained by the indemnifying party would be inappropriate due to actual
or potential differing interests between such indemnified party and any other
party represented by such counsel in such proceeding. The failure to deliver
written notice to the indemnifying party within a reasonable time of the
commencement of any such action, if prejudicial to its ability to defend such
action, shall relieve such indemnifying party of any liability to the
indemnified party under this Section 6 to the extent of such prejudice, but the
omission so to deliver written notice to the indemnifying party will not relieve
it of any liability that it may have to any indemnified party otherwise than
under this Section 6.
7. Miscellaneous.
7.1 No Press Releases; Confidentiality. All publicity relating to the
Transaction Agreements and the transactions contemplated thereby shall be
subject to the mutual approval of the parties and no public announcement or
disclosure of the terms or existence of the Transaction Agreements or the
transactions contemplated thereby shall be made by either party (or any of its
affiliates or representatives) without the prior written consent of the other.
Notwithstanding the foregoing, to the extent either party is required by
applicable law to disclose publicly or to make any public announcement of the
terms or existence of the Transaction Agreements or the transactions
contemplated thereby, such party shall, to the extent possible within the
applicable time constraints, give the other party reasonable, prior notice of
such disclosure and use its best efforts to agree with the other party on the
form of such disclosure.
7.2 Entire Agreement; Successors and Assigns. The Transaction
Agreements constitute the entire agreement between the parties relating to the
subject matter thereof and no party shall be liable or bound to the other in any
manner by any representations, warranties or covenants except as specifically
set forth therein. Any previous agreement among the parties with respect to the
Purchased Shares is superseded by the Transaction Agreements. The terms of this
Agreement shall inure to the benefit of and be binding upon the respective
successors and permitted assigns of the parties. Except as expressly provided
herein, nothing in this Agreement, expressed or implied, is intended to confer
upon any party, other than the parties hereto, any rights, remedies, obligations
or liabilities under or by reason of this Agreement.
7.3 Survival of Representations and Warranties. Notwithstanding any
right of DCEO fully to investigate the affairs of Merrimac and notwithstanding
any knowledge of facts determined or determinable by DCEO pursuant to such right
of investigation, DCEO has the
13
right to rely fully upon the representations, warranties, covenants and
agreements of Merrimac contained in this Agreement or in any documents delivered
pursuant to this Agreement. All such representations and warranties of Merrimac
and DCEO shall survive the execution and delivery of this Agreement and the
Closing hereunder for two years. The covenants of Merrimac set forth in Section
5 shall remain in effect as set forth therein.
7.4 Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York without regard to principles
of conflicts of law.
7.5 Counterparts. This Agreement may be executed in counterparts, each
of which shall be deemed an original, but all of which together shall constitute
one and the same instrument.
7.6 Headings. The headings of the sections of this Agreement are for
convenience and shall not by themselves determine the interpretation of this
Agreement.
7.7 Notices. Any notice required or permitted hereunder shall be given
in writing and shall be deemed effectively given (i) upon personal delivery or
facsimile transmissions (with confirmation of receipt); (ii) five business days
after having been sent by registered or certified mail, return receipt
requested, postage prepaid; or (iii) one business day after deposit with a
nationally recognized overnight carrier, specifying next business day delivery,
with written verification of receipt, in each case, to the party to be notified.
Any notice to Merrimac shall be sent to:
Merrimac Industries, Inc.
41 Fairfield Place
West Caldwell, New Jersey 07006
Attn: Mason N. Carter, President
Fax: (973) 882-5989
with a copy to:
Edward H. Cohen, Esq.
Rosenman & Colin LLP
575 Madison Avenue
New York, New York 10022
Fax: (212) 940-8776
Any notice to DCEO or DuPont shall be sent to:
14
DuPont Chemical and Energy Operations, Inc.
1007 Market Street, Room D-8052
Wilmington, Delaware 19898
Attn: Corporate Secretary
Fax: (302) 773-5176
with a copy to:
Assistant Corporate Secretary
E.I. du Pont de Nemours and Company
1007 Market Street
Wilmington, Delaware 19898
Fax: (302) 773-5176
and
E.I. du Pont de Nemours and Company
14 TW Alexander Drive
Research Triangle Park, North Carolina 27709-3999
Attn: Vice President and General Manager,
DuPont Electronic Technologies
7.8 Severability. In case any provision of this Agreement shall be
determined to be invalid, illegal or unenforceable, the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or
impaired thereby.
7.9 Expenses. Irrespective of whether the Closing occurs, each party
shall pay all costs and expenses that it incurs with respect to the negotiation,
execution, delivery and performance of this Agreement and the transaction
contemplated hereby.
7.10 Amendments and Waivers. Unless a particular provision or section
of this Agreement requires otherwise explicitly in a particular instance, any
provision of this Agreement may be amended and the observance of any provision
of this Agreement may be waived (either generally or in a particular instance
and either retroactively or prospectively), only with the written consent of
Merrimac and DCEO.
15
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as
of the date first above written.
MERRIMAC INDUSTRIES, INC.
By: /s/ Mason N. Carter
---------------------------------------
Name: Mason N. Carter
Title: Chairman, President and Chief
Executive Officer
DUPONT CHEMICAL AND
ENERGY OPERATIONS, INC.
By: /s/ David B. Miller
---------------------------------------
Name: David B. Miller
Title: Attorney-in-fact
E.I. DUPONT DE NEMOURS AND COMPANY
By: /s/ David B. Miller
---------------------------------------
Name: David B. Miller
Title: Vice President and General Manager
DuPont Electronic Technologies
16
Schedule 5.4
------------
Non-DuPont
----------
Directors DuPont Directors Total
--------- ---------------- -----
7 1 8
8 1 9
9 2 11
10 2 12
11 2 13
12 2 14
13 3 16
14 3 17
15 3 18
16 3 19
17 3 20
18 4 22
19 4 23
20 4 24
21 4 25
17